Skip to main content
. 2025 Jan 31;12(4):644–653. doi: 10.1093/nop/npaf011

Table 3.

Results EORTC QLQ-BN20 for All Responders (n = 120)

Domains Inclusion Month 1 Month 2 Month 3 Month 6 Month 9 Month 12
Patients alive 155 154 151 146 123 98 81
PROMs responders (response rate) 120 (77%) 102 (66%) 93 (62%) 77 (53%) 62 (50%) 43 (44%) 36 (44%)
Mean (SD)
Headaches 21.9 (29.8) 19.7 (24.7) 19.9 (26.5) 23.1 (27.0) 17.2 (27.5) 12.9 (23.0) 15.7 (24.5)
Visual disorder 11.8 (19.0) 9.8 (18.7) 11.7 (19.3) 10.8 (17.4) 9.7 (15.8) 6.9 (11.6) 9.0 (17.0)
Seizures 2.5 (9.8) 1.6 (8.6) 1.4 (6.8) 2.1 (8.2) 4.8 (14.5) 2.3 (8.6) 1.9 (7.7)
Motor dysfunction 21.8 (22.8) 18.8 (21.4) 18.8 (18.6) 17.9 (21.2) 21.5 (24.2) 15.2 (18.9) 12.3 (15.4)
Communication deficit 11.8 (18.2) 8.2 (15.6) 9.6 (15.1) 9.1 (14.8) 13.2 (22.9) 9.3 (15.7) 9.6 (14.3)
Drowsiness 28.6 (27.1) 35.3 (24.3) 31.9 (22.4) 33.8 (23.1) 31.7 (24.7) 25.0 (26.0) 22.9 (22.5)
Weakness of legs 17.5 (27.5) 24.5 (28.9) 22.2 (27.1) 23.1 (30.1) 26.5 (30.0) 17.5 (28.7) 13.0 (18.3)

Motor dysfunction scores shown in bold values.